Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Background: CML patients with different types of BCR-ABL ...
Functional status of neuroendocrine tumors among elderly patients: A large population-based study using SEER-Medicare data. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results